메뉴 건너뛰기





Volumn 52, Issue 1 Suppl, 2012, Pages

Clinical pharmacology basis of deriving dosing recommendations for dabigatran in patients with severe renal impairment.

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DRUG DERIVATIVE; N ((2 (((4 (AMINOIMINOMETHYL)PHENYL)AMINO)METHYL) 1 METHYL 1H BENZIMIDAZOL 5 YL)CARBONYL) N 2 PYRIDINYL BETA ALANINE; N-((2-(((4-(AMINOIMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-BETA-ALANINE;

EID: 84859800192     PISSN: None     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270011415527     Document Type: Article
Times cited : (74)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.